Jenoptik stock gains after H1 orders reach EUR 723.4 million

Published on 10/07/2026 at 13:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Jenoptik stock traded at EUR 43.96 on Xetra on October 6, up 3.92 percent. The 2026 EBITDA margin outlook stands at 20-21 percent.

Photonik-Reinraum mit Technikern in Schutzanzügen bei Optik-Montage — Jenoptik AG DE0006229107 zeigt Techniker in Reinraum bei präziser optischer Linsen Montage, Illustration mit AI erstellt.

Jenoptik stock (ISIN DE000A2NB601) was last at EUR 43.96 on Xetra on October 6, 2026, after a 3.92 percent daily gain. The main business signal remains the first-half order surge, which lifted intake to EUR 723.4 million, up 53 percent year over year.

Orders strengthen the growth case

According to Yahoo Finance on August 12, 2026, first-half revenue increased 1 percent to EUR 503.2 million, while EBITDA reached EUR 98.9 million, a 25.5 percent increase from the prior-year period. The EBITDA margin stood at 19.7 percent.

The earnings mix is important for investors because the stronger order flow is concentrated in semiconductor and biophotonics activities. Jenoptik's first-half net income reached EUR 39.7 million, up 57.1 percent year over year, according to IT Boltwise.

Guidance moves toward the upper half

Management expects full-year 2026 revenue growth of 5 to 9 percent and an EBITDA margin of 20 to 21 percent. The margin range is higher than the original 19 to 21 percent corridor, while continuing weakness in automotive-related activities remains a counter-factor, as described in the Yahoo Finance transcript.

The company also says its strategy review is progressing, with key findings possible toward the end of 2026 at the earliest. The next scheduled financial date is November 10, 2026, when Jenoptik lists its January to September quarterly update on its Jenoptik investor page.

Analysts see further upside

Jefferies raised its Jenoptik target from EUR 45 to EUR 48 and kept a Buy rating on September 10, 2026, according to MarketScreener. The same source lists a Buy consensus from 8 analysts and an average target of EUR 47.19, which is 7.35 percent above the EUR 43.96 Xetra price.

That comparison leaves the stock close to the analyst average, so execution matters more than a simple order rebound. The 53 percent order increase is powerful, but management has also warned that some biophotonics orders arrived earlier than expected and may make later quarterly comparisons less even.

Jenoptik stock stays near EUR 44

Jenoptik stock was last quoted at EUR 43.96 on Xetra on October 6, 2026. The 3.92 percent session gain puts the share below the analyst average target while the 20 to 21 percent EBITDA margin outlook provides the next operating benchmark.